Massive study aims to unlock secrets of rare blood disorder
NCT ID NCT07205861
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study reviews medical records from over 1,200 people with immune thrombotic thrombocytopenic purpura (iTTP), a rare and life-threatening blood disorder. The goal is to understand long-term health problems, such as heart disease and thinking issues, that survivors face. By analyzing past data, researchers hope to find better ways to manage the disease and improve quality of life for patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AUTOIMMUNE DISEASES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Service d'Hématologie Hôpital Saint-Antoine
RECRUITINGParis, 75012, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can better healthcare access save hearts after prison?
- Can lifestyle choices after a stroke extend life and prevent a second one?
- Could a simple health chat slash heart disease and cancer risk?
- One scan, many answers: can a new CT predict heart risks after stenting?
- Strumming for the brain: could ukulele lessons sharpen minds in MS?
- Digital coaching aims to boost heart health in obesity